Table 1.
HF | AL | AH | VL | VH | |
---|---|---|---|---|---|
Body weight gain (g/16 weeks) |
268.6 ± 10.6a |
247.2 ± 10.3ab |
230.5 ± 5.1b |
235.3 ± 12.8b |
259.6 ± 12.3ab |
Calorie intake (kcal/day) |
107.8 ± 2.2 |
104.1 ± 3.1 |
107.4 ± 1.5 |
104.1 ± 3.1 |
106.2 ± 1.8 |
WAT mass (g/100 g BW) |
|
|
|
|
|
Epididymal WAT |
3.4 ± 0.1a |
3.4 ± 0.0ab |
3.3 ± 0.0ab |
3.0 ± 0.1b |
3.2 ± 0.1ab |
Perirenal WAT |
4.8 ± 0.2a |
4.5 ± 0.1ab |
4.3 ± 0.1b |
4.3 ± 0.1b |
4.4 ± 0.1ab |
Plasma TG (mg/dL) |
186.6 ± 8.9a |
155.5 ± 10.8b |
152.7 ± 8.1b |
154.6 ± 10.4b |
164.6 ± 10.1b |
Plasma leptin (ng/mL) |
10.2 ± 0.5 |
10.20 ± 0.9 |
9.9 ± 0.4 |
8.5 ± 0.4 |
9.84 ± 0.6 |
Hepatic TG (mg/g liver) | 36.7 ± 4.5a | 30.8 ± 3.0ab | 30.0 ± 4.7ab | 23.8 ± 1.9b | 28.4 ± 3.1ab |
Mean ± SEM (n = 10 per group). abMeans not sharing common letters are significantly different between groups at p < 0.05 by Duncan’s multiple range tests. BW, body weight; WAT, white adipose tissue; TG, triglycerides; HF, high fat diet; AL, high fat with HF, high fat diet; AL, HF with low-dose acetic acid; AH, HF with high-dose acetic acid; VL, HF with low-dose PV; VH, HF with high-dose PV.